<DOC>
	<DOCNO>NCT00150319</DOCNO>
	<brief_summary>This study investigate pharmacokinetics , safety tolerability intravenous voriconazole SBECD patient moderate renal insufficiency</brief_summary>
	<brief_title>An Open-Label Study To Assess The Pharmacokinetics , Safety And Toleration Of VfendÂ® ; Following Multiple Dosing With Vfend</brief_title>
	<detailed_description>The study put hold first subject enrol experienced serious adverse event ( SAE ) renal failure chronic receiving I.V . dose Day 1 . The study take hold subject recover independent consultant deem SAE treatment relate ; however , site unwilling enroll additional subject . Another site , base New Orleans , damage hurricane Katrina unable enroll subject . A decision make sponsor terminate study 11 Apr 2006 due poor study enrollment . There safety efficacy concern regard study decision terminate trial .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Patients moderate renal insufficiency Active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>